nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—Rosuvastatin—atherosclerosis	0.062	0.093	CbGbCtD
Lansoprazole—ABCG2—Ezetimibe—atherosclerosis	0.062	0.093	CbGbCtD
Lansoprazole—ABCG2—Pravastatin—atherosclerosis	0.0564	0.0846	CbGbCtD
Lansoprazole—CYP2C8—Simvastatin—atherosclerosis	0.0307	0.0461	CbGbCtD
Lansoprazole—CYP2C8—Pravastatin—atherosclerosis	0.0301	0.0451	CbGbCtD
Lansoprazole—CYP2C8—Lovastatin—atherosclerosis	0.0301	0.0451	CbGbCtD
Lansoprazole—CYP2C19—Rosuvastatin—atherosclerosis	0.0277	0.0416	CbGbCtD
Lansoprazole—CYP2C19—Simvastatin—atherosclerosis	0.0258	0.0387	CbGbCtD
Lansoprazole—CYP2C19—Lovastatin—atherosclerosis	0.0252	0.0378	CbGbCtD
Lansoprazole—CYP2D6—Niacin—atherosclerosis	0.0248	0.0372	CbGbCtD
Lansoprazole—CYP2C9—Rosuvastatin—atherosclerosis	0.023	0.0346	CbGbCtD
Lansoprazole—ABCB1—Ezetimibe—atherosclerosis	0.0224	0.0335	CbGbCtD
Lansoprazole—CYP2C9—Simvastatin—atherosclerosis	0.0214	0.0321	CbGbCtD
Lansoprazole—CYP2C9—Lovastatin—atherosclerosis	0.021	0.0315	CbGbCtD
Lansoprazole—CYP2C9—Pravastatin—atherosclerosis	0.021	0.0315	CbGbCtD
Lansoprazole—ABCB1—Simvastatin—atherosclerosis	0.0208	0.0312	CbGbCtD
Lansoprazole—ABCB1—Lovastatin—atherosclerosis	0.0203	0.0305	CbGbCtD
Lansoprazole—ABCB1—Pravastatin—atherosclerosis	0.0203	0.0305	CbGbCtD
Lansoprazole—CYP2D6—Simvastatin—atherosclerosis	0.0196	0.0294	CbGbCtD
Lansoprazole—CYP2D6—Pravastatin—atherosclerosis	0.0192	0.0288	CbGbCtD
Lansoprazole—CYP2D6—Lovastatin—atherosclerosis	0.0192	0.0288	CbGbCtD
Lansoprazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0134	0.0201	CbGbCtD
Lansoprazole—CYP3A4—Ezetimibe—atherosclerosis	0.0134	0.0201	CbGbCtD
Lansoprazole—CYP3A4—Simvastatin—atherosclerosis	0.0125	0.0187	CbGbCtD
Lansoprazole—CYP3A4—Pravastatin—atherosclerosis	0.0122	0.0183	CbGbCtD
Lansoprazole—CYP3A4—Lovastatin—atherosclerosis	0.0122	0.0183	CbGbCtD
Lansoprazole—Muscle spasms—Simvastatin—atherosclerosis	0.000277	0.00131	CcSEcCtD
Lansoprazole—Vertigo—Lovastatin—atherosclerosis	0.000277	0.00131	CcSEcCtD
Lansoprazole—Angioedema—Ezetimibe—atherosclerosis	0.000276	0.00131	CcSEcCtD
Lansoprazole—Angiopathy—Niacin—atherosclerosis	0.000276	0.00131	CcSEcCtD
Lansoprazole—Leukopenia—Lovastatin—atherosclerosis	0.000276	0.00131	CcSEcCtD
Lansoprazole—Chills—Niacin—atherosclerosis	0.000273	0.00129	CcSEcCtD
Lansoprazole—Malaise—Ezetimibe—atherosclerosis	0.000273	0.00129	CcSEcCtD
Lansoprazole—Vision blurred—Simvastatin—atherosclerosis	0.000272	0.00129	CcSEcCtD
Lansoprazole—Arrhythmia—Niacin—atherosclerosis	0.000272	0.00129	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00027	0.00128	CcSEcCtD
Lansoprazole—Tremor—Simvastatin—atherosclerosis	0.00027	0.00128	CcSEcCtD
Lansoprazole—Alopecia—Niacin—atherosclerosis	0.000269	0.00127	CcSEcCtD
Lansoprazole—Chills—Pravastatin—atherosclerosis	0.000269	0.00127	CcSEcCtD
Lansoprazole—Insomnia—Rosuvastatin—atherosclerosis	0.000268	0.00127	CcSEcCtD
Lansoprazole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000268	0.00127	CcSEcCtD
Lansoprazole—Arrhythmia—Pravastatin—atherosclerosis	0.000267	0.00127	CcSEcCtD
Lansoprazole—Palpitations—Ezetimibe—atherosclerosis	0.000267	0.00127	CcSEcCtD
Lansoprazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000267	0.00126	CcSEcCtD
Lansoprazole—Anaemia—Simvastatin—atherosclerosis	0.000266	0.00126	CcSEcCtD
Lansoprazole—Erythema—Niacin—atherosclerosis	0.000265	0.00125	CcSEcCtD
Lansoprazole—Malnutrition—Niacin—atherosclerosis	0.000265	0.00125	CcSEcCtD
Lansoprazole—Alopecia—Pravastatin—atherosclerosis	0.000265	0.00125	CcSEcCtD
Lansoprazole—Cough—Ezetimibe—atherosclerosis	0.000264	0.00125	CcSEcCtD
Lansoprazole—Angioedema—Simvastatin—atherosclerosis	0.000263	0.00125	CcSEcCtD
Lansoprazole—Myalgia—Lovastatin—atherosclerosis	0.000262	0.00124	CcSEcCtD
Lansoprazole—Chest pain—Lovastatin—atherosclerosis	0.000262	0.00124	CcSEcCtD
Lansoprazole—Arthralgia—Lovastatin—atherosclerosis	0.000262	0.00124	CcSEcCtD
Lansoprazole—Anxiety—Lovastatin—atherosclerosis	0.000262	0.00124	CcSEcCtD
Lansoprazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Lansoprazole—Hypertension—Ezetimibe—atherosclerosis	0.000261	0.00124	CcSEcCtD
Lansoprazole—Flatulence—Niacin—atherosclerosis	0.000261	0.00124	CcSEcCtD
Lansoprazole—Malaise—Simvastatin—atherosclerosis	0.00026	0.00123	CcSEcCtD
Lansoprazole—Tension—Niacin—atherosclerosis	0.00026	0.00123	CcSEcCtD
Lansoprazole—Discomfort—Lovastatin—atherosclerosis	0.000259	0.00123	CcSEcCtD
Lansoprazole—Vertigo—Simvastatin—atherosclerosis	0.000259	0.00123	CcSEcCtD
Lansoprazole—Leukopenia—Simvastatin—atherosclerosis	0.000258	0.00122	CcSEcCtD
Lansoprazole—Myalgia—Ezetimibe—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Chest pain—Ezetimibe—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Arthralgia—Ezetimibe—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Nervousness—Niacin—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Flatulence—Pravastatin—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Dry mouth—Lovastatin—atherosclerosis	0.000257	0.00122	CcSEcCtD
Lansoprazole—Tension—Pravastatin—atherosclerosis	0.000256	0.00121	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000256	0.00121	CcSEcCtD
Lansoprazole—Dysgeusia—Pravastatin—atherosclerosis	0.000255	0.00121	CcSEcCtD
Lansoprazole—Muscle spasms—Niacin—atherosclerosis	0.000255	0.00121	CcSEcCtD
Lansoprazole—Discomfort—Ezetimibe—atherosclerosis	0.000254	0.0012	CcSEcCtD
Lansoprazole—Pain—Rosuvastatin—atherosclerosis	0.000254	0.0012	CcSEcCtD
Lansoprazole—Constipation—Rosuvastatin—atherosclerosis	0.000254	0.0012	CcSEcCtD
Lansoprazole—Confusional state—Lovastatin—atherosclerosis	0.000254	0.0012	CcSEcCtD
Lansoprazole—Nervousness—Pravastatin—atherosclerosis	0.000253	0.0012	CcSEcCtD
Lansoprazole—Dry mouth—Ezetimibe—atherosclerosis	0.000252	0.00119	CcSEcCtD
Lansoprazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000252	0.00119	CcSEcCtD
Lansoprazole—Muscle spasms—Pravastatin—atherosclerosis	0.000251	0.00119	CcSEcCtD
Lansoprazole—Infection—Lovastatin—atherosclerosis	0.00025	0.00118	CcSEcCtD
Lansoprazole—Vision blurred—Niacin—atherosclerosis	0.000249	0.00118	CcSEcCtD
Lansoprazole—Confusional state—Ezetimibe—atherosclerosis	0.000249	0.00118	CcSEcCtD
Lansoprazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000247	0.00117	CcSEcCtD
Lansoprazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000246	0.00117	CcSEcCtD
Lansoprazole—Vision blurred—Pravastatin—atherosclerosis	0.000246	0.00116	CcSEcCtD
Lansoprazole—Arthralgia—Simvastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Chest pain—Simvastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Myalgia—Simvastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Infection—Ezetimibe—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Anxiety—Simvastatin—atherosclerosis	0.000245	0.00116	CcSEcCtD
Lansoprazole—Tremor—Pravastatin—atherosclerosis	0.000244	0.00116	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000243	0.00115	CcSEcCtD
Lansoprazole—Discomfort—Simvastatin—atherosclerosis	0.000243	0.00115	CcSEcCtD
Lansoprazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000242	0.00115	CcSEcCtD
Lansoprazole—Angioedema—Niacin—atherosclerosis	0.000242	0.00115	CcSEcCtD
Lansoprazole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000242	0.00115	CcSEcCtD
Lansoprazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000242	0.00114	CcSEcCtD
Lansoprazole—Anaemia—Pravastatin—atherosclerosis	0.000241	0.00114	CcSEcCtD
Lansoprazole—Anorexia—Lovastatin—atherosclerosis	0.00024	0.00114	CcSEcCtD
Lansoprazole—Skin disorder—Ezetimibe—atherosclerosis	0.00024	0.00114	CcSEcCtD
Lansoprazole—Angioedema—Pravastatin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Lansoprazole—Vertigo—Niacin—atherosclerosis	0.000238	0.00113	CcSEcCtD
Lansoprazole—Syncope—Niacin—atherosclerosis	0.000237	0.00112	CcSEcCtD
Lansoprazole—Confusional state—Simvastatin—atherosclerosis	0.000237	0.00112	CcSEcCtD
Lansoprazole—Leukopenia—Niacin—atherosclerosis	0.000237	0.00112	CcSEcCtD
Lansoprazole—Urticaria—Rosuvastatin—atherosclerosis	0.000236	0.00112	CcSEcCtD
Lansoprazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000235	0.00111	CcSEcCtD
Lansoprazole—Oedema—Simvastatin—atherosclerosis	0.000235	0.00111	CcSEcCtD
Lansoprazole—Malaise—Pravastatin—atherosclerosis	0.000235	0.00111	CcSEcCtD
Lansoprazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000235	0.00111	CcSEcCtD
Lansoprazole—Vertigo—Pravastatin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Lansoprazole—Palpitations—Niacin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Lansoprazole—Infection—Simvastatin—atherosclerosis	0.000234	0.00111	CcSEcCtD
Lansoprazole—Leukopenia—Pravastatin—atherosclerosis	0.000233	0.00111	CcSEcCtD
Lansoprazole—Loss of consciousness—Niacin—atherosclerosis	0.000233	0.0011	CcSEcCtD
Lansoprazole—Cough—Niacin—atherosclerosis	0.000231	0.00109	CcSEcCtD
Lansoprazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.00023	0.00109	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000229	0.00109	CcSEcCtD
Lansoprazole—Insomnia—Lovastatin—atherosclerosis	0.000228	0.00108	CcSEcCtD
Lansoprazole—Cough—Pravastatin—atherosclerosis	0.000227	0.00108	CcSEcCtD
Lansoprazole—Paraesthesia—Lovastatin—atherosclerosis	0.000226	0.00107	CcSEcCtD
Lansoprazole—Arthralgia—Niacin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Lansoprazole—Myalgia—Niacin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Lansoprazole—Hypertension—Pravastatin—atherosclerosis	0.000225	0.00107	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000225	0.00106	CcSEcCtD
Lansoprazole—Anorexia—Simvastatin—atherosclerosis	0.000224	0.00106	CcSEcCtD
Lansoprazole—Dyspnoea—Lovastatin—atherosclerosis	0.000224	0.00106	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000224	0.00106	CcSEcCtD
Lansoprazole—Insomnia—Ezetimibe—atherosclerosis	0.000223	0.00106	CcSEcCtD
Lansoprazole—Chest pain—Pravastatin—atherosclerosis	0.000222	0.00105	CcSEcCtD
Lansoprazole—Arthralgia—Pravastatin—atherosclerosis	0.000222	0.00105	CcSEcCtD
Lansoprazole—Myalgia—Pravastatin—atherosclerosis	0.000222	0.00105	CcSEcCtD
Lansoprazole—Paraesthesia—Ezetimibe—atherosclerosis	0.000222	0.00105	CcSEcCtD
Lansoprazole—Dyspepsia—Lovastatin—atherosclerosis	0.000221	0.00105	CcSEcCtD
Lansoprazole—Anxiety—Pravastatin—atherosclerosis	0.000221	0.00105	CcSEcCtD
Lansoprazole—Dry mouth—Niacin—atherosclerosis	0.00022	0.00104	CcSEcCtD
Lansoprazole—Dyspnoea—Ezetimibe—atherosclerosis	0.00022	0.00104	CcSEcCtD
Lansoprazole—Discomfort—Pravastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Lansoprazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Lansoprazole—Decreased appetite—Lovastatin—atherosclerosis	0.000219	0.00104	CcSEcCtD
Lansoprazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000217	0.00103	CcSEcCtD
Lansoprazole—Fatigue—Lovastatin—atherosclerosis	0.000217	0.00103	CcSEcCtD
Lansoprazole—Oedema—Niacin—atherosclerosis	0.000216	0.00102	CcSEcCtD
Lansoprazole—Anaphylactic shock—Niacin—atherosclerosis	0.000216	0.00102	CcSEcCtD
Lansoprazole—Pain—Lovastatin—atherosclerosis	0.000215	0.00102	CcSEcCtD
Lansoprazole—Constipation—Lovastatin—atherosclerosis	0.000215	0.00102	CcSEcCtD
Lansoprazole—Confusional state—Pravastatin—atherosclerosis	0.000214	0.00102	CcSEcCtD
Lansoprazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000214	0.00102	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000214	0.00102	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Asthenia—Rosuvastatin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Insomnia—Simvastatin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Oedema—Pravastatin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Fatigue—Ezetimibe—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Shock—Niacin—atherosclerosis	0.000213	0.00101	CcSEcCtD
Lansoprazole—Infection—Pravastatin—atherosclerosis	0.000211	0.001	CcSEcCtD
Lansoprazole—Paraesthesia—Simvastatin—atherosclerosis	0.000211	0.001	CcSEcCtD
Lansoprazole—Constipation—Ezetimibe—atherosclerosis	0.000211	0.000999	CcSEcCtD
Lansoprazole—Pain—Ezetimibe—atherosclerosis	0.000211	0.000999	CcSEcCtD
Lansoprazole—Tachycardia—Niacin—atherosclerosis	0.000211	0.000999	CcSEcCtD
Lansoprazole—Pruritus—Rosuvastatin—atherosclerosis	0.00021	0.000995	CcSEcCtD
Lansoprazole—Skin disorder—Niacin—atherosclerosis	0.00021	0.000994	CcSEcCtD
Lansoprazole—Dyspnoea—Simvastatin—atherosclerosis	0.00021	0.000994	CcSEcCtD
Lansoprazole—Hyperhidrosis—Niacin—atherosclerosis	0.000209	0.000989	CcSEcCtD
Lansoprazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000208	0.000987	CcSEcCtD
Lansoprazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000207	0.000982	CcSEcCtD
Lansoprazole—Dyspepsia—Simvastatin—atherosclerosis	0.000207	0.000981	CcSEcCtD
Lansoprazole—Anorexia—Niacin—atherosclerosis	0.000206	0.000975	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000206	0.000974	CcSEcCtD
Lansoprazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000206	0.000974	CcSEcCtD
Lansoprazole—Decreased appetite—Simvastatin—atherosclerosis	0.000205	0.000969	CcSEcCtD
Lansoprazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000203	0.000963	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000203	0.000962	CcSEcCtD
Lansoprazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000203	0.000962	CcSEcCtD
Lansoprazole—Fatigue—Simvastatin—atherosclerosis	0.000203	0.000961	CcSEcCtD
Lansoprazole—Anorexia—Pravastatin—atherosclerosis	0.000203	0.00096	CcSEcCtD
Lansoprazole—Hypotension—Niacin—atherosclerosis	0.000202	0.000956	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000202	0.000956	CcSEcCtD
Lansoprazole—Pain—Simvastatin—atherosclerosis	0.000201	0.000953	CcSEcCtD
Lansoprazole—Constipation—Simvastatin—atherosclerosis	0.000201	0.000953	CcSEcCtD
Lansoprazole—Urticaria—Lovastatin—atherosclerosis	0.0002	0.000947	CcSEcCtD
Lansoprazole—Abdominal pain—Lovastatin—atherosclerosis	0.000199	0.000942	CcSEcCtD
Lansoprazole—Body temperature increased—Lovastatin—atherosclerosis	0.000199	0.000942	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000197	0.000932	CcSEcCtD
Lansoprazole—Dizziness—Rosuvastatin—atherosclerosis	0.000196	0.00093	CcSEcCtD
Lansoprazole—Urticaria—Ezetimibe—atherosclerosis	0.000196	0.000928	CcSEcCtD
Lansoprazole—Insomnia—Niacin—atherosclerosis	0.000195	0.000926	CcSEcCtD
Lansoprazole—Abdominal pain—Ezetimibe—atherosclerosis	0.000195	0.000924	CcSEcCtD
Lansoprazole—Body temperature increased—Ezetimibe—atherosclerosis	0.000195	0.000924	CcSEcCtD
Lansoprazole—Paraesthesia—Niacin—atherosclerosis	0.000194	0.000919	CcSEcCtD
Lansoprazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000194	0.000918	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000194	0.000918	CcSEcCtD
Lansoprazole—Dyspnoea—Niacin—atherosclerosis	0.000193	0.000912	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000192	0.000911	CcSEcCtD
Lansoprazole—Insomnia—Pravastatin—atherosclerosis	0.000192	0.000911	CcSEcCtD
Lansoprazole—Somnolence—Niacin—atherosclerosis	0.000192	0.00091	CcSEcCtD
Lansoprazole—Paraesthesia—Pravastatin—atherosclerosis	0.000191	0.000905	CcSEcCtD
Lansoprazole—Dyspepsia—Niacin—atherosclerosis	0.00019	0.000901	CcSEcCtD
Lansoprazole—Dyspnoea—Pravastatin—atherosclerosis	0.00019	0.000898	CcSEcCtD
Lansoprazole—Decreased appetite—Niacin—atherosclerosis	0.000188	0.00089	CcSEcCtD
Lansoprazole—Dyspepsia—Pravastatin—atherosclerosis	0.000187	0.000887	CcSEcCtD
Lansoprazole—Rash—Rosuvastatin—atherosclerosis	0.000187	0.000887	CcSEcCtD
Lansoprazole—Dermatitis—Rosuvastatin—atherosclerosis	0.000187	0.000886	CcSEcCtD
Lansoprazole—Urticaria—Simvastatin—atherosclerosis	0.000187	0.000885	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000187	0.000884	CcSEcCtD
Lansoprazole—Abdominal pain—Simvastatin—atherosclerosis	0.000186	0.000881	CcSEcCtD
Lansoprazole—Body temperature increased—Simvastatin—atherosclerosis	0.000186	0.000881	CcSEcCtD
Lansoprazole—Headache—Rosuvastatin—atherosclerosis	0.000186	0.000881	CcSEcCtD
Lansoprazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000185	0.000878	CcSEcCtD
Lansoprazole—Decreased appetite—Pravastatin—atherosclerosis	0.000185	0.000876	CcSEcCtD
Lansoprazole—Pain—Niacin—atherosclerosis	0.000185	0.000875	CcSEcCtD
Lansoprazole—Fatigue—Pravastatin—atherosclerosis	0.000183	0.000869	CcSEcCtD
Lansoprazole—Pain—Pravastatin—atherosclerosis	0.000182	0.000862	CcSEcCtD
Lansoprazole—Constipation—Pravastatin—atherosclerosis	0.000182	0.000862	CcSEcCtD
Lansoprazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000182	0.000861	CcSEcCtD
Lansoprazole—Asthenia—Lovastatin—atherosclerosis	0.00018	0.000855	CcSEcCtD
Lansoprazole—Pruritus—Lovastatin—atherosclerosis	0.000178	0.000843	CcSEcCtD
Lansoprazole—Asthenia—Ezetimibe—atherosclerosis	0.000177	0.000839	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Niacin—atherosclerosis	0.000177	0.000837	CcSEcCtD
Lansoprazole—Nausea—Rosuvastatin—atherosclerosis	0.000176	0.000835	CcSEcCtD
Lansoprazole—Feeling abnormal—Pravastatin—atherosclerosis	0.000175	0.00083	CcSEcCtD
Lansoprazole—Pruritus—Ezetimibe—atherosclerosis	0.000175	0.000827	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000174	0.000824	CcSEcCtD
Lansoprazole—Hypersensitivity—Simvastatin—atherosclerosis	0.000173	0.000821	CcSEcCtD
Lansoprazole—Diarrhoea—Lovastatin—atherosclerosis	0.000172	0.000815	CcSEcCtD
Lansoprazole—Urticaria—Niacin—atherosclerosis	0.000172	0.000813	CcSEcCtD
Lansoprazole—Body temperature increased—Niacin—atherosclerosis	0.000171	0.000809	CcSEcCtD
Lansoprazole—Abdominal pain—Niacin—atherosclerosis	0.000171	0.000809	CcSEcCtD
Lansoprazole—Urticaria—Pravastatin—atherosclerosis	0.000169	0.0008	CcSEcCtD
Lansoprazole—Asthenia—Simvastatin—atherosclerosis	0.000169	0.0008	CcSEcCtD
Lansoprazole—Diarrhoea—Ezetimibe—atherosclerosis	0.000169	0.0008	CcSEcCtD
Lansoprazole—Abdominal pain—Pravastatin—atherosclerosis	0.000168	0.000797	CcSEcCtD
Lansoprazole—Body temperature increased—Pravastatin—atherosclerosis	0.000168	0.000797	CcSEcCtD
Lansoprazole—Pruritus—Simvastatin—atherosclerosis	0.000166	0.000789	CcSEcCtD
Lansoprazole—Dizziness—Lovastatin—atherosclerosis	0.000166	0.000788	CcSEcCtD
Lansoprazole—Dizziness—Ezetimibe—atherosclerosis	0.000163	0.000773	CcSEcCtD
Lansoprazole—Diarrhoea—Simvastatin—atherosclerosis	0.000161	0.000763	CcSEcCtD
Lansoprazole—Vomiting—Lovastatin—atherosclerosis	0.00016	0.000758	CcSEcCtD
Lansoprazole—Hypersensitivity—Niacin—atherosclerosis	0.000159	0.000754	CcSEcCtD
Lansoprazole—Rash—Lovastatin—atherosclerosis	0.000159	0.000751	CcSEcCtD
Lansoprazole—Dermatitis—Lovastatin—atherosclerosis	0.000158	0.000751	CcSEcCtD
Lansoprazole—Headache—Lovastatin—atherosclerosis	0.000158	0.000746	CcSEcCtD
Lansoprazole—Vomiting—Ezetimibe—atherosclerosis	0.000157	0.000743	CcSEcCtD
Lansoprazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000157	0.000742	CcSEcCtD
Lansoprazole—Dizziness—Simvastatin—atherosclerosis	0.000156	0.000737	CcSEcCtD
Lansoprazole—Rash—Ezetimibe—atherosclerosis	0.000156	0.000737	CcSEcCtD
Lansoprazole—Dermatitis—Ezetimibe—atherosclerosis	0.000155	0.000736	CcSEcCtD
Lansoprazole—Asthenia—Niacin—atherosclerosis	0.000155	0.000734	CcSEcCtD
Lansoprazole—Headache—Ezetimibe—atherosclerosis	0.000155	0.000732	CcSEcCtD
Lansoprazole—Pruritus—Niacin—atherosclerosis	0.000153	0.000724	CcSEcCtD
Lansoprazole—Asthenia—Pravastatin—atherosclerosis	0.000153	0.000723	CcSEcCtD
Lansoprazole—Pruritus—Pravastatin—atherosclerosis	0.000151	0.000713	CcSEcCtD
Lansoprazole—Vomiting—Simvastatin—atherosclerosis	0.00015	0.000709	CcSEcCtD
Lansoprazole—Nausea—Lovastatin—atherosclerosis	0.000149	0.000708	CcSEcCtD
Lansoprazole—Rash—Simvastatin—atherosclerosis	0.000148	0.000703	CcSEcCtD
Lansoprazole—Dermatitis—Simvastatin—atherosclerosis	0.000148	0.000702	CcSEcCtD
Lansoprazole—Diarrhoea—Niacin—atherosclerosis	0.000148	0.0007	CcSEcCtD
Lansoprazole—Headache—Simvastatin—atherosclerosis	0.000147	0.000698	CcSEcCtD
Lansoprazole—Nausea—Ezetimibe—atherosclerosis	0.000147	0.000694	CcSEcCtD
Lansoprazole—Diarrhoea—Pravastatin—atherosclerosis	0.000146	0.000689	CcSEcCtD
Lansoprazole—Dizziness—Niacin—atherosclerosis	0.000143	0.000677	CcSEcCtD
Lansoprazole—Dizziness—Pravastatin—atherosclerosis	0.000141	0.000666	CcSEcCtD
Lansoprazole—Nausea—Simvastatin—atherosclerosis	0.00014	0.000662	CcSEcCtD
Lansoprazole—Vomiting—Niacin—atherosclerosis	0.000137	0.000651	CcSEcCtD
Lansoprazole—Rash—Niacin—atherosclerosis	0.000136	0.000645	CcSEcCtD
Lansoprazole—Dermatitis—Niacin—atherosclerosis	0.000136	0.000645	CcSEcCtD
Lansoprazole—Headache—Niacin—atherosclerosis	0.000135	0.000641	CcSEcCtD
Lansoprazole—Vomiting—Pravastatin—atherosclerosis	0.000135	0.000641	CcSEcCtD
Lansoprazole—Rash—Pravastatin—atherosclerosis	0.000134	0.000635	CcSEcCtD
Lansoprazole—Dermatitis—Pravastatin—atherosclerosis	0.000134	0.000635	CcSEcCtD
Lansoprazole—Headache—Pravastatin—atherosclerosis	0.000133	0.000631	CcSEcCtD
Lansoprazole—Nausea—Niacin—atherosclerosis	0.000128	0.000608	CcSEcCtD
Lansoprazole—Nausea—Pravastatin—atherosclerosis	0.000126	0.000599	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—BGN—atherosclerosis	9.18e-06	7.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.14e-06	7.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—atherosclerosis	9.12e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.12e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AGT—atherosclerosis	9.11e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CETP—atherosclerosis	9.1e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA5—atherosclerosis	9.09e-06	7.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LCAT—atherosclerosis	9.08e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FABP4—atherosclerosis	9.08e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.95e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.94e-06	7.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SCARB1—atherosclerosis	8.93e-06	7.31e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—atherosclerosis	8.93e-06	7.3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA4—atherosclerosis	8.91e-06	7.29e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LIPC—atherosclerosis	8.89e-06	7.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.87e-06	7.26e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CG—atherosclerosis	8.86e-06	7.25e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAV1—atherosclerosis	8.84e-06	7.24e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOC3—atherosclerosis	8.84e-06	7.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.83e-06	7.22e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOA1—atherosclerosis	8.82e-06	7.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.82e-06	7.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LIPC—atherosclerosis	8.81e-06	7.21e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LDLR—atherosclerosis	8.78e-06	7.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOC3—atherosclerosis	8.76e-06	7.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.75e-06	7.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	8.75e-06	7.16e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SCARB1—atherosclerosis	8.72e-06	7.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LDLR—atherosclerosis	8.71e-06	7.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.7e-06	7.12e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.65e-06	7.08e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CETP—atherosclerosis	8.58e-06	7.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.57e-06	7.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.55e-06	7e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—atherosclerosis	8.55e-06	6.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.52e-06	6.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CETP—atherosclerosis	8.5e-06	6.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALOX5—atherosclerosis	8.45e-06	6.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.43e-06	6.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.42e-06	6.89e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—INS—atherosclerosis	8.38e-06	6.86e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMGCR—atherosclerosis	8.23e-06	6.74e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.21e-06	6.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.14e-06	6.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.09e-06	6.62e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.07e-06	6.6e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CG—atherosclerosis	8.06e-06	6.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.93e-06	6.49e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HMOX1—atherosclerosis	7.88e-06	6.45e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.81e-06	6.39e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—atherosclerosis	7.78e-06	6.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.76e-06	6.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.69e-06	6.29e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—atherosclerosis	7.68e-06	6.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA2—atherosclerosis	7.67e-06	6.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.67e-06	6.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.67e-06	6.28e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.67e-06	6.28e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—INS—atherosclerosis	7.63e-06	6.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.61e-06	6.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NAMPT—atherosclerosis	7.58e-06	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.58e-06	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOB—atherosclerosis	7.55e-06	6.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.54e-06	6.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LIPC—atherosclerosis	7.53e-06	6.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.52e-06	6.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOC3—atherosclerosis	7.49e-06	6.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LDLR—atherosclerosis	7.44e-06	6.09e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—atherosclerosis	7.35e-06	6.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—atherosclerosis	7.34e-06	6.01e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCA1—atherosclerosis	7.34e-06	6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPA—atherosclerosis	7.32e-06	5.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CETP—atherosclerosis	7.27e-06	5.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—atherosclerosis	7.23e-06	5.91e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LPL—atherosclerosis	7.21e-06	5.9e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BGN—atherosclerosis	7.09e-06	5.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—atherosclerosis	7.03e-06	5.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA5—atherosclerosis	7.02e-06	5.74e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—atherosclerosis	6.99e-06	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.96e-06	5.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.94e-06	5.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOB—atherosclerosis	6.92e-06	5.66e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.91e-06	5.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.85e-06	5.61e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD36—atherosclerosis	6.85e-06	5.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.78e-06	5.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.75e-06	5.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.73e-06	5.51e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—atherosclerosis	6.72e-06	5.5e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—atherosclerosis	6.69e-06	5.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LPL—atherosclerosis	6.61e-06	5.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMGCR—atherosclerosis	6.57e-06	5.38e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.52e-06	5.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—atherosclerosis	6.49e-06	5.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.45e-06	5.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—atherosclerosis	6.45e-06	5.28e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARA—atherosclerosis	6.37e-06	5.21e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—atherosclerosis	6.3e-06	5.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—atherosclerosis	6.28e-06	5.14e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOB—atherosclerosis	6.18e-06	5.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—atherosclerosis	6.17e-06	5.05e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—atherosclerosis	6.12e-06	5e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—atherosclerosis	6.04e-06	4.94e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOB—atherosclerosis	6.03e-06	4.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.01e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—atherosclerosis	5.99e-06	4.9e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—atherosclerosis	5.97e-06	4.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.95e-06	4.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.93e-06	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.93e-06	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—atherosclerosis	5.9e-06	4.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.88e-06	4.81e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—atherosclerosis	5.87e-06	4.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.86e-06	4.79e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.85e-06	4.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARA—atherosclerosis	5.84e-06	4.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LIPC—atherosclerosis	5.81e-06	4.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOC3—atherosclerosis	5.78e-06	4.73e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—atherosclerosis	5.76e-06	4.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—atherosclerosis	5.76e-06	4.71e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LDLR—atherosclerosis	5.74e-06	4.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOB—atherosclerosis	5.68e-06	4.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—atherosclerosis	5.65e-06	4.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOB—atherosclerosis	5.63e-06	4.61e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—atherosclerosis	5.62e-06	4.6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CETP—atherosclerosis	5.61e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—atherosclerosis	5.61e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—atherosclerosis	5.54e-06	4.53e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.53e-06	4.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—atherosclerosis	5.49e-06	4.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.48e-06	4.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—atherosclerosis	5.48e-06	4.48e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—atherosclerosis	5.47e-06	4.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	5.45e-06	4.46e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—atherosclerosis	5.43e-06	4.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—atherosclerosis	5.38e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.37e-06	4.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.31e-06	4.35e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—atherosclerosis	5.29e-06	4.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—atherosclerosis	5.26e-06	4.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—atherosclerosis	5.25e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—atherosclerosis	5.24e-06	4.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARA—atherosclerosis	5.21e-06	4.26e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—atherosclerosis	5.18e-06	4.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—atherosclerosis	5.16e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—atherosclerosis	5.16e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—atherosclerosis	5.11e-06	4.18e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARA—atherosclerosis	5.09e-06	4.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.07e-06	4.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—atherosclerosis	5.05e-06	4.13e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—atherosclerosis	5.03e-06	4.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5e-06	4.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—atherosclerosis	4.94e-06	4.05e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—atherosclerosis	4.93e-06	4.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—atherosclerosis	4.9e-06	4.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—atherosclerosis	4.89e-06	4e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.89e-06	4e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.84e-06	3.96e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—atherosclerosis	4.83e-06	3.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—atherosclerosis	4.83e-06	3.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOB—atherosclerosis	4.81e-06	3.94e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARA—atherosclerosis	4.79e-06	3.92e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—atherosclerosis	4.78e-06	3.91e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—atherosclerosis	4.77e-06	3.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARA—atherosclerosis	4.75e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—atherosclerosis	4.73e-06	3.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—atherosclerosis	4.73e-06	3.87e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.68e-06	3.83e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—atherosclerosis	4.64e-06	3.8e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—atherosclerosis	4.6e-06	3.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—atherosclerosis	4.6e-06	3.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—atherosclerosis	4.58e-06	3.75e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—atherosclerosis	4.55e-06	3.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—atherosclerosis	4.53e-06	3.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.52e-06	3.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—atherosclerosis	4.51e-06	3.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—atherosclerosis	4.51e-06	3.69e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—atherosclerosis	4.5e-06	3.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—atherosclerosis	4.48e-06	3.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—atherosclerosis	4.47e-06	3.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.46e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—atherosclerosis	4.46e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—atherosclerosis	4.37e-06	3.57e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.36e-06	3.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—atherosclerosis	4.34e-06	3.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—atherosclerosis	4.31e-06	3.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—atherosclerosis	4.22e-06	3.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—atherosclerosis	4.2e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—atherosclerosis	4.15e-06	3.4e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—atherosclerosis	4.14e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.14e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—atherosclerosis	4.12e-06	3.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.1e-06	3.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.07e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARA—atherosclerosis	4.06e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—atherosclerosis	3.96e-06	3.24e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—atherosclerosis	3.93e-06	3.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—atherosclerosis	3.93e-06	3.21e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—atherosclerosis	3.89e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.88e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—atherosclerosis	3.87e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—atherosclerosis	3.85e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—atherosclerosis	3.85e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—atherosclerosis	3.82e-06	3.12e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—atherosclerosis	3.81e-06	3.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.8e-06	3.11e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—atherosclerosis	3.78e-06	3.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOB—atherosclerosis	3.72e-06	3.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—atherosclerosis	3.7e-06	3.03e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—atherosclerosis	3.62e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.61e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—atherosclerosis	3.56e-06	2.91e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—atherosclerosis	3.55e-06	2.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—atherosclerosis	3.53e-06	2.89e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.48e-06	2.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—atherosclerosis	3.46e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—atherosclerosis	3.41e-06	2.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.39e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—atherosclerosis	3.38e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—atherosclerosis	3.38e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—atherosclerosis	3.37e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—atherosclerosis	3.36e-06	2.75e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—atherosclerosis	3.31e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—atherosclerosis	3.29e-06	2.69e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.19e-06	2.61e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARA—atherosclerosis	3.13e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.12e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.09e-06	2.53e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—atherosclerosis	3.07e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—atherosclerosis	3.03e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—atherosclerosis	3.02e-06	2.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—atherosclerosis	2.97e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—atherosclerosis	2.95e-06	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—atherosclerosis	2.94e-06	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—atherosclerosis	2.89e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.68e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.64e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—atherosclerosis	2.59e-06	2.12e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—atherosclerosis	2.54e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—atherosclerosis	2.33e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—atherosclerosis	2.23e-06	1.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—atherosclerosis	2.08e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.04e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—atherosclerosis	1.91e-06	1.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—atherosclerosis	1.7e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—atherosclerosis	1.66e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—atherosclerosis	1.57e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—atherosclerosis	1.55e-06	1.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—atherosclerosis	1.33e-06	1.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—atherosclerosis	1.02e-06	8.38e-06	CbGpPWpGaD
